Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-03-07 @ 9:04 AM
Study NCT ID:
NCT03441100
Status:
COMPLETED
Last Update Posted:
2025-02-04
First Post:
2018-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TCR-engineered T Cells in Solid Tumors: IMA202-101
Sponsor:
Immatics US, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IMA202-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None